Chemomab Therapeutics (CMMB) Times Interest Earned (2018 - 2025)
Chemomab Therapeutics (CMMB) posted Times Interest Earned of $12550.0 for Q4 2025, up 47.13% on a QoQ basis from $8529.7 in Q4 2024, and up 47.13% year-over-year from $8529.7 in Q4 2024.
Chemomab Therapeutics (CMMB) Times Interest Earned (2018 - 2025) Analysis & Trends
Chemomab Therapeutics' Times Interest Earned history runs 8 years deep, the most recent figure standing at $12550.0 for Q4 2025.
- Quarterly Times Interest Earned rose 47.13% year-over-year to $12550.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20115.0 (up 135.81% YoY) and the FY2025 annual result came in at $0.82, up 19.71% from the prior year.
- Times Interest Earned was $12550.0 for Q4 2025 at Chemomab Therapeutics, up from $8529.7 in the prior quarter.
- Across five years, Times Interest Earned topped out at $12550.0 in Q4 2025 and bottomed at $0.86 in Q4 2021.
- A 5-year average of $4216.6 and a median of $1.2 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned dropped 10.16% — and 2024, when it soared 790712.57%.
- Chemomab Therapeutics' Times Interest Earned stood at $0.86 in 2021, then jumped by 39.56% to $1.2 in 2022, then dropped by 10.16% to $1.08 in 2023, then surged by 790712.57% to $8529.7 in 2024, then surged by 47.13% to $12550.0 in 2025.
- Business Quant data shows CMMB's Times Interest Earned at $12550.0 in Q4 2025, $8529.7 in Q4 2024, and $1.08 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Chemomab Therapeutics | 704.11 Mn | 693.75 Mn | - | 12,550.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,550.00 |
| Dec 31, 2024 | 8,529.74 |
| Dec 31, 2023 | 1.08 |
| Dec 31, 2022 | 1.20 |
| Dec 31, 2021 | 0.86 |
| Dec 31, 2020 | -24.85 |
| Dec 31, 2019 | -12,689.60 |
| Sep 30, 2019 | 0.31 |
| Jun 30, 2019 | 246.83 |
| Mar 31, 2019 | 247.00 |
| Dec 31, 2018 | 62.00 |
| Sep 30, 2018 | 34.79 |
| Jun 30, 2018 | 5.16 |